There is no data on overdose in humans. Cyramza has been administered in a Phase 1 study up to 10 mg/kg every two weeks without reaching a maximum tolerated dose. In case of overdose, supportive therapy should be used.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
